These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35781334)

  • 21. The role of electrophysiology study in risk stratification of cardiac sarcoidosis patients: Meta-analyses and systemic review.
    Adhaduk M; Paudel B; Liu K; Ashwath M; Giudici M
    Int J Cardiol; 2022 Feb; 349():55-61. PubMed ID: 34864075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragmented QRS as a predictor of cardiac events in patients with cardiac sarcoidosis.
    Ogura S; Nakamura K; Morita H; Nakagawa K; Nishii N; Akagi S; Toh N; Takaya Y; Yoshida M; Miyoshi T; Watanabe A; Ito H
    J Cardiol; 2022 Mar; 79(3):446-452. PubMed ID: 34799215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.
    Nordenswan HK; Lehtonen J; Ekström K; Kandolin R; Simonen P; Mäyränpää M; Vihinen T; Miettinen H; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Kokkonen J; Alatalo A; Pietilä-Effati P; Utriainen S; Kupari M
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006145. PubMed ID: 30354309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres.
    Fussner LA; Karlstedt E; Hodge DO; Fine NM; Kalra S; Carmona EM; Utz JP; Isaac DL; Cooper LT
    Eur J Heart Fail; 2018 Dec; 20(12):1713-1720. PubMed ID: 30378224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis.
    Hutt E; Brizneda MV; Goldar G; Aguilera J; Wang TKM; Taimeh Z; Culver D; Callahan T; Tang WHW; Cremer PC; Jaber WA; Ribeiro Neto ML; Jellis CL
    Europace; 2023 Aug; 25(9):. PubMed ID: 37721485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.
    Kouranos V; Tzelepis GE; Rapti A; Mavrogeni S; Aggeli K; Douskou M; Prasad S; Koulouris N; Sfikakis P; Wells A; Gialafos E
    JACC Cardiovasc Imaging; 2017 Dec; 10(12):1437-1447. PubMed ID: 28330653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of Serum Uric Acid in Hospitalized Heart Failure Patients With Preserved Ejection Fraction (from the Japanese Nationwide Multicenter Registry).
    Kobayashi Y; Omote K; Nagai T; Kamiya K; Konishi T; Sato T; Kato Y; Komoriyama H; Tsujinaga S; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Am J Cardiol; 2020 Mar; 125(5):772-776. PubMed ID: 31898963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C;
    Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis and Outcomes of Clinically Diagnosed Cardiac Sarcoidosis Without Positive Endomyocardial Biopsy Findings.
    Kusano K; Ishibashi K; Noda T; Nakajima K; Nakasuka K; Terasaki S; Hattori Y; Nagayama T; Mori K; Takaya Y; Miyamoto K; Nagase S; Aiba T; Yasuda S; Kitakaze M; Kamakura S; Yazaki Y; Morimoto SI; Isobe M; Terasaki F
    JACC Asia; 2021 Dec; 1(3):385-395. PubMed ID: 36341209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart Failure, Atrioventricular Block, and Ventricular Tachycardia in Sarcoidosis.
    Rosenthal DG; Fang CD; Groh CA; Nah G; Vittinghoff E; Dewland TA; Vedantham V; Marcus GM
    J Am Heart Assoc; 2021 Feb; 10(5):e017692. PubMed ID: 33599141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.
    Koplan BA; Soejima K; Baughman K; Epstein LM; Stevenson WG
    Heart Rhythm; 2006 Aug; 3(8):924-9. PubMed ID: 16876741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry.
    Jefic D; Joel B; Good E; Morady F; Rosman H; Knight B; Bogun F
    Heart Rhythm; 2009 Feb; 6(2):189-95. PubMed ID: 19187909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of resting heart rate in atrial fibrillation patients with heart failure with reduced ejection fraction.
    Suzuki S; Motoki H; Kanzaki Y; Maruyama T; Hashizume N; Kozuka A; Yahikozawa K; Kuwahara K
    Heart Vessels; 2020 Aug; 35(8):1109-1115. PubMed ID: 32144498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status　- Report From the Japanese Nationwide Multicenter Registry.
    Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of Prognostic Heart Failure Models in Patients With Nonischemic Cardiomyopathy Undergoing Ventricular Tachycardia Ablation.
    Muser D; Liang JJ; Castro SA; Lanera C; Enriquez A; Kuo L; Magnani S; Birati EY; Lin D; Schaller R; Supple G; Zado E; Garcia FC; Nazarian S; Dixit S; Frankel DS; Callans DJ; Marchlinski FE; Santangeli P
    JACC Clin Electrophysiol; 2019 Jul; 5(7):801-813. PubMed ID: 31320008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Utility of Brain Natriuretic Peptide in Asymptomatic Patients With Significant Mitral Regurgitation and Preserved Left Ventricular Ejection Fraction.
    Mentias A; Patel K; Patel H; Gillinov AM; Rodriguez LL; Svensson LG; Mihaljevic T; Sabik JF; Griffin BP; Desai MY
    Am J Cardiol; 2016 Jan; 117(2):258-63. PubMed ID: 26651455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
    J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.